PATRICK FARLEY: Open Payments
NPI 1922051549 · WHEATON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,165 in 172 payments from 24 companies in 2025. Trend: 2023 $131 · 2024 $1,194 · 2025 $4,165
Food & beverage: $3,978Education: $187
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $717 |
| ANI Pharmaceuticals, Inc. | 30 | $548 |
| UCB, Inc. | 20 | $483 |
| Janssen Biotech, Inc. | 10 | $410 |
| Novartis Pharmaceuticals Corporation | 13 | $373 |
| Amgen Inc. | 18 | $372 |
| Lilly USA, LLC | 7 | $201 |
| Janssen Pharmaceuticals, Inc | 4 | $138 |
| Radius Health, Inc. | 5 | $117 |
| PFIZER INC. | 5 | $111 |
Products named: TREMFYA, Bimzelx, RINVOQ, PURIFIED CORTROPHIN GEL, SOVUNA, SKYRIZI, COSENTYX, TALTZ.
Industry payments across MD — which companies pay providers there.
